Latest Research And Development News

FBR Limited has completed the final tranche of its $6.3 million placement, enabling significant cost reductions and operational consolidation that position the company for a more sustainable future.

AVITA Medical reported a strong first quarter with revenues up 67% to $18.5 million, driven by expanded commercial sales and new product introductions. Despite a narrower net loss, the company faces ongoing challenges from revenue covenants and macroeconomic pressures.

Sparc Technologies has launched a Share Purchase Plan offering eligible shareholders the chance to buy new shares at a 28.6% discount, aiming to raise up to $500,000 to fund key growth initiatives.

Imdex Limited reported a stabilisation in global exploration activity after a prolonged downturn, highlighting resilience despite a 19% revenue dip in 3Q25 and outlining a growth strategy focused on technology and integrated solutions.

Altech Batteries has launched an operational pilot plant in Germany producing its proprietary Silumina Anodes, promising a 50% increase in lithium-ion battery capacity with improved longevity.

Enlitic has signed a binding MoU with GE HealthCare to deliver up to A$50 million in migration services over five years, contingent on a A$10 million equity raise that the company has now initiated.

Papyrus Australia has issued a revised Appendix 4C for the March 2025 quarter, correcting the treatment of $527k in R&D expenditure previously reported as cash payments. This adjustment also impacts prior monthly and quarterly cash flow reports dating back to November 2024.

Enlitic, Inc. has launched a two-tranche institutional placement to raise A$10 million, underpinning its strategic collaboration with GE HealthCare and fueling expansion in AI-enabled medical imaging data migration.

Enlitic has formalised a binding MOU with GE HealthCare to deliver multi-million-dollar migration services, contingent on raising A$10 million through a new capital placement. This partnership and funding round mark a pivotal step in Enlitic’s growth strategy within AI-driven medical imaging.

Next Science Limited has successfully had a derivative complaint dismissed in Florida, while continuing legal action against former employees for breach of post-employment restraints.

HITIQ Ltd has successfully completed a $680,000 placement and launched a $2.92 million rights issue, positioning the company to fund its strategic shift towards the consumer market and expand its footprint in the US.

Anagenics Limited reported a cash outflow of $424K for Q3 2025 but maintains robust liquidity with $1.48 million in available funding, supported by a mix of secured and unsecured loans.